-
EP3967298
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3967298
| EP3967298 - AEROSOL COMPOSITION FOR ORAL USE [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 23.09.2022 Database last updated on 24.08.2024 | |
| Former | The application has been published Status updated on 11.02.2022 | Most recent event Tooltip | 02.07.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Uniwersytet Rzeszowski Al. Rejtana 16C 35-959 Rzeszów / PL | For all designated states Podkarpackie Centrum Innowacji sp. z o.o. ul. Teofila Lenartowicza 4 35-051 Rzeszów / PL | [2022/11] | Inventor(s) | 01 /
Tutka, Piotr 20-554 Lublin / PL | 02 /
Czernicka-Kubicka, Anna 35-601 Rzeszów / PL | 03 /
Wróblewski, Karol 37-114 Bia obrzegi / PL | 04 /
Ko odziejczyk, Patrycjusz 35-106 Rzeszów / PL | 05 /
Bieniasz, Mateusz 37-205 Zarzecze / PL | [2022/11] | Representative(s) | Bartula-Toch, Marta Kancelaria Prawno-Patentowa Patent Krzeslawicka 3A 31-416 Kraków / PL | [2022/11] | Application number, filing date | 21182872.8 | 30.06.2021 | [2022/11] | Priority number, date | PL20200434519 | 30.06.2020 Original published format: PL 43451920 | [2022/11] | Filing language | PL | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3967298 | Date: | 16.03.2022 | Language: | EN | [2022/11] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 15.02.2022 | Classification | IPC: | A61K9/08, A61K9/12, A61K31/439, A61K47/10, A61P25/34, A24B15/167 | [2022/11] | CPC: |
A61K31/439 (EP);
A24B15/167 (EP);
A61K47/10 (EP);
A61K9/08 (EP);
A61K9/12 (EP);
A61P25/34 (EP)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/43] |
| Former [2022/11] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | KH | Not yet paid | MA | Not yet paid | MD | Not yet paid | TN | Not yet paid | Title | German: | AEROSOLZUSAMMENSETZUNG ZUR ORALEN ANWENDUNG | [2022/11] | English: | AEROSOL COMPOSITION FOR ORAL USE | [2022/11] | French: | COMPOSITION EN AÉROSOL À USAGE ORAL | [2022/11] | Examination procedure | 16.09.2022 | Examination requested [2022/43] | 16.09.2022 | Date on which the examining division has become responsible | 10.10.2022 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time | 20.01.2023 | Amendment by applicant (claims and/or description) | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report | 20.12.2022 | Request for further processing filed | 20.12.2022 | Full payment received (date of receipt of payment) Request granted | 30.01.2023 | Decision despatched | Fees paid | Renewal fee | 30.06.2023 | Renewal fee patent year 03 | 01.07.2024 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [YD]CN101428021 (JIANGSU ZEUKOV PHARMACEUTICAL [CN]) [YD] 1-11 * examples 49, 58 *; | [YD]EP2815741 (CHANGNING DEKANG BIOTECHNOLOGY CO LTD [CN]) [YD] 1-11 * abstract *; | [Y]RU2593585 (OBSHSHESTVO S OGRANICHENNOJ OTVETSTVENNOSTYU RITEK-FARMA [RU]) [Y] 1-11 * page 6, lines 7-9; examples 1-3 *; | [Y]PL416496 (ZALEWSKI PIOTR STANISŁAW [PL]) [Y] 1-11 * Formulations 1-12;; example 1 * * examples 2-3; claim 1 *; | [AP]EP3834814 (ADAMED PHARMA S A [PL]) [AP] 1-11* example 2 * | by applicant | CN101428021 | EP2815741 | WO2016060576 | PT2361081T |